- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 69-83 of
1,482 results
No. 1
Document
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co., Ltd., 1:23-cv-00106, No. 1 (N.D.W.Va. Dec. 27, 2023)
|
|
Cite Document
No. 436
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 436 (N.D.W.Va. Apr. 28, 2023)
|
|
Cite Document
No. 427
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 427 (N.D.W.Va. Apr. 19, 2023)
|
|
Cite Document
No. 425
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 425 (N.D.W.Va. Apr. 14, 2023)
|
|
Cite Document
No. 824
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 824 (N.D.W.Va. Sep. 6, 2024)
|
|
Cite Document
No. 818
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 818 (N.D.W.Va. Aug. 21, 2024)
|
|
Cite Document
No. 227
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 227 (N.D.W.Va. Oct. 30, 2024)
|
|
Cite Document
55 Final Written Decision original: Dismissing in Part and Denying in Part Patent Ow...
Document
IPR2023-00442, No. 55 Final Written Decision original - Dismissing in Part and Denying in Part Patent Owner’s Motion to Exclude Evidence 37 CFR § 4264c Determining Challenged Claims 1, 3–1...
|
|
Cite Document
No. 220
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 220 (N.D.W.Va. Oct. 10, 2024)
|
|
Cite Document
54 Other Hearing transcript: Other Hearing transcript
Document
IPR2023-00442, No. 54 Other Hearing transcript - Other Hearing transcript (P.T.A.B. May. 20, 2024)
|
|
Cite Document
No. 215
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 215 (N.D.W.Va. Sep. 13, 2024)
|
|
Cite Document
No. 213
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 213 (N.D.W.Va. Aug. 30, 2024)
|
|
Cite Document
No. 212
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 212 (N.D.W.Va. Aug. 30, 2024)
|
|
Cite Document
47 Order Other: ORDER Setting Oral Argument
Document
IPR2023-00442, No. 47 Order Other - ORDER Setting Oral Argument (P.T.A.B. Apr. 2, 2024)
|
|
Cite Document
No. 207
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 207 (N.D.W.Va. Jul. 26, 2024)
|
|
Cite Document
